https://medical.berentx.com/resource/efficacy-of-intrathecal-adrabetadex-in-infantile-onset-niemann-pick-disease-type-c-is-supported-by-survival-clinical-and-biomarker-data/ 2026-09-16T19:08:00+00:00 https://medical.berentx.com/resource/neurofilament-light-chain-in-cerebrospinal-fluid-as-a-novel-biomarker-in-evaluating-both-clinical-severity-and-therapeutic-response-in-niemann-pick-disease-type-c1/ 2026-09-16T19:33:30+00:00 https://medical.berentx.com/resource/a-phase-1-2-open-label-nonrandomized-clinical-trial-of-intravenous-2-hydroxypropyl-%ce%b2-cyclodextrin-for-acute-liver-disease-in-infants-with-niemann-pick-c1/ 2026-09-16T19:43:14+00:00 https://medical.berentx.com/resource/anesthetic-management-of-pediatric-patients-with-niemann-pick-disease-type-c-for-intrathecal-2-hydroxypropyl-%ce%b2-cyclodextrin-injection/ 2026-09-16T19:43:31+00:00 https://medical.berentx.com/resource/characterization-of-hydroxypropyl-beta-cyclodextrins-used-in-the-treatment-of-niemann-pick-disease-type-c1/ 2026-09-16T19:43:57+00:00 https://medical.berentx.com/resource/consistently-high-agreement-between-independent-raters-of-niemann-pick-type-c1-clinical-severity-scale-in-phase-2-3-trial/ 2026-09-16T19:44:31+00:00 https://medical.berentx.com/resource/convergent-validity-of-the-fine-motor-speech-and-cognitive-domains-of-the-5-domain-niemann-pick-disease-type-c-clinical-severity-scale/ 2026-09-16T19:45:29+00:00 https://medical.berentx.com/resource/elevated-cerebrospinal-fluid-total-tau-in-niemann-pick-disease-type-c1-correlation-with-clinical-severity-and-response-to-therapeutic-interventions/ 2026-09-16T19:46:01+00:00 https://medical.berentx.com/resource/intrathecal-2-hydroxypropyl-%ce%b2-cyclodextrin-decreases-neurological-disease-progression-in-niemann-pick-disease-type-c1-a-non-randomised-open-label-phase-1-2-trial/ 2026-09-16T19:46:39+00:00 https://medical.berentx.com/resource/long-term-neuropsychological-outcomes-from-an-open-label-phase-i-iia-trial-of-2-hydroxypropyl-%ce%b2-cyclodextrins-vts-270-in-niemann-pick-disease-type-c1/ 2026-09-16T19:47:10+00:00 https://medical.berentx.com/resource/long-term-treatment-of-niemann-pick-type-c1-disease-with-intrathecal-2-hydroxypropyl-%ce%b2-cyclodextrin/ 2026-09-16T19:47:36+00:00 https://medical.berentx.com/resource/low-risk-profile-of-long-term-repeated-lumbar-puncture-for-intrathecal-delivery-of-2-hydroxypropyl-beta-cyclodextrin-in-patients-with-niemann-pick-type-c/ 2026-09-16T19:48:02+00:00 https://medical.berentx.com/resource/transcriptome-of-hp%ce%b2cd-treated-niemann-pick-disease-type-c1-cells-highlights-gpnmb-as-a-biomarker-for-therapeutics/ 2026-09-16T19:48:28+00:00 https://medical.berentx.com/resource/utility-of-24s-hydroxycholesterol-as-a-proximal-biomarker-to-monitor-long-term-intrathecal-adrabetadex-therapy-in-individuals-with-niemann-pick-disease-type-c1/ 2026-09-16T19:48:52+00:00 https://medical.berentx.com/resource/substantial-survival-benefit-and-slowing-of-disease-progression-with-adrabetadex-treatment-in-individuals-with-infantile-onset-niemann-pick-disease-type-c-npc-3/ 2026-09-16T20:15:43+00:00 https://medical.berentx.com/resource/adrabetadex-treatment-in-individuals-with-niemann-pick-diseasetype-c1-re-establishes-cholesterol-trafficking-resulting-in-decreased-markers-of-neuronal-damage-and-cell-death-2/ 2026-09-16T20:15:59+00:00 https://medical.berentx.com/resource/substantial-survival-benefit-in-individuals-with-infantile-onset-niemann-pick-disease-type-c-treated-with-adrabetadex/ 2026-09-16T20:16:06+00:00 https://medical.berentx.com/resource/restoration-of-cholesterol-trafficking-results-in-decreased-markers-of-neuronal-damage-in-individuals-with-niemann-pick-disease-type-c1/ 2026-09-16T20:16:13+00:00 https://medical.berentx.com/resource/substantial-survival-benefit-in-individuals-with-infantile-onset-niemann-pick-disease-type-c-treated-with-adrabetadex-2/ 2026-09-16T20:16:26+00:00 https://medical.berentx.com/resource/restoration-of-cholesterol-trafficking-results-in-decreased-markers-of-neuronal-damage-in-individuals-with-niemann-pick-disease-type-c1-2/ 2026-09-16T20:16:34+00:00 https://medical.berentx.com/resource/adrabetadex-treatment-in-individuals-with-niemann-pick-disease-type-c1-re-establishes-cholesterol-trafficking-resulting-in-decreased-markers-of-neuronal-damage-and-cell-death/ 2026-09-16T20:17:24+00:00 https://medical.berentx.com/resource/substantial-survival-benefit-and-slowing-of-disease-progression-with-adrabetadex-treatment-in-individuals-with-infantile-onset-niemann-pick-disease-type-c-npc/ 2026-09-16T20:19:35+00:00 https://medical.berentx.com/resource/eposter-adrabetadex-treatment-in-individuals-with-niemann-pick-disease-type-c1-re-establishes-cholesterol-trafficking-resulting-in-decreased-markers-of-neuronal-damage-and-cell-death/ 2026-09-16T20:20:42+00:00 https://medical.berentx.com/resource/presentation-survival-clinical-and-biomarker-data-support-the-efficacy-of-intrathecal-adrabetadex-in-niemann-pick-disease-type-c/ 2026-09-16T20:22:29+00:00 https://medical.berentx.com/resource/npc-overview/ 2026-09-29T16:02:33+00:00 https://medical.berentx.com/resource/2025-consensus-clinical-management-guidelines-for-niemann-pick-disease-type-c/ 2026-09-29T16:03:22+00:00 https://medical.berentx.com/resource/npc-suspicion-index-npc-si/ 2026-09-29T16:04:00+00:00 https://medical.berentx.com/resource/estimating-the-prevalence-of-niemann-pick-disease-type-c-npc-in-the-united-states/ 2026-09-29T16:05:10+00:00 https://medical.berentx.com/resource/clinical-disease-characteristics-of-patients-with-niemann-pick-disease-type-c-findings-from-the-international-niemann-pick-disease-registry-inpdr/ 2026-09-29T16:05:47+00:00 https://medical.berentx.com/resource/consensus-clinical-management-guidelines-for-niemann-pick-disease-type-c/ 2026-09-29T16:06:19+00:00 https://medical.berentx.com/resource/high-incidence-of-unrecognized-visceral-neurological-late-onset-niemann-pick-disease-type-c1-predicted-by-analysis-of-massively-parallel-sequencing-data-sets/ 2026-09-29T16:06:46+00:00 https://medical.berentx.com/resource/infantile-onset-niemann-pick-disease-type-c-i-npc-disease-state-backgrounder/ 2026-09-30T17:07:40+00:00 https://medical.berentx.com/resource/poster-survival-outcomes-by-baseline-disease-burden-in-participants-with-infantile-onset-niemann-pick-disease-type-c-treated-with-adrabetadex/ 2026-10-22T05:50:56+00:00 https://medical.berentx.com/resource/poster-outcomes-in-participants-with-infantile-onset-niemann-pick-disease-type-c-receiving-prompt-and-sustained-treatment-with-adrabetadex/ 2026-10-22T16:11:04+00:00 https://medical.berentx.com/resource/poster-early-evidence-of-an-emerging-npc-treatment-paradigm-adrabetadex-use-alongside-arimoclomol-and-or-n-acetyl-l-leucine/ 2026-10-22T16:12:53+00:00 https://medical.berentx.com/resource/poster-adrabetadex-alone-or-in-combination-with-arimoclomol-and-levacetylleucine-promotes-oligodendrocyte-proliferation-synaptic-network-growth-and-myelination-in-an-in-vitro-mouse-model-of-niemann/ 2026-10-22T16:14:35+00:00 https://medical.berentx.com/resource/poster-mechanism-of-action-of-adrabetadex-for-treatment-of-niemann-pick-disease-type-c/ 2026-10-22T16:17:20+00:00 https://medical.berentx.com/resource/poster-disease-modifying-effects-of-centrally-administered-adrabetadex-for-treatment-of-niemann-pick-disease-type-c/ 2026-10-22T16:20:27+00:00 https://medical.berentx.com/resource/poster-a-target-trial-emulation-framework-for-externally-controlled-survival-analyses-ininfantile-onset-niemann-pick-disease-type-c/ 2026-11-06T15:49:53+00:00 https://medical.berentx.com/resource/efficacy-of-intrathecal-adrabetadex-in-infantile-onset-niemann-pick-disease-type-c-is-supported-by-survival-clinical-and-biomarker-data-poster/ 2026-11-06T15:53:00+00:00 https://medical.berentx.com/resource/case-report-of-siblings-with-infantile-onset-niemann-pick-type-c-i-npc-initiating-adrabetadex-at-different-ages-and-intervals-from-disease-onset-poster/ 2026-11-06T15:59:57+00:00 https://medical.berentx.com/resource/survival-outcomes-by-baseline-disease-burden-in-participants-with-infantile-onset-niemann-pick-disease-type-c-treated-with-adrabetadex-poster/ 2026-11-06T19:00:24+00:00 https://medical.berentx.com/resource/outcomes-in-participants-with-infantile-onset-niemann-pick-disease-type-c-receiving-prompt-and-sustained-treatment-with-adrabetadex-poster/ 2026-11-06T19:05:19+00:00 https://medical.berentx.com/resource/early-evidence-of-an-emerging-npc-treatment-paradigm-adrabetadex-use-alongside-arimoclomol-and-or-levacetylleucine-poster/ 2026-11-06T19:08:21+00:00 https://medical.berentx.com/resource/video-npc-mechanism-of-disease/ 2026-11-06T19:36:30+00:00 https://medical.berentx.com/resource/npc-fact-sheet/ 2026-11-09T14:59:32+00:00 https://medical.berentx.com/resource/npc-treatment-landscape/ 2026-11-09T15:01:53+00:00 https://medical.berentx.com/resource/clinical-and-family-burden-across-i-npc-severity-groups/ 2026-11-09T15:05:47+00:00